Akorn Uncategorized Contracts & Agreements

55 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Akorn, Inc. Clawback Policy revised November 6, 2019
Akorn
Pharmaceuticals
2020
Description of Akorn, Inc.'s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Akorn
Pharmaceuticals
LA
2020
Form Letter Agreement
Akorn
Pharmaceuticals
IL
2020
Amended Standstill Agreement
Akorn
Pharmaceuticals
NY
2019
Form of Recoupment Letter Agreement
Akorn
Pharmaceuticals
IL
2019
Offer Letter dated February 4, 2019
Akorn
Pharmaceuticals
2019
Form of Offer Letter Agreement effective January 24, 2019, between Akorn, Inc. and Christopher Young
Akorn
Pharmaceuticals
2019
Letter Agreement dated January 7, 2019 between Bruce Kutinsky and Akorn, Inc
Akorn
Pharmaceuticals
2019
Letter Agreement dated December 27, 2018 between Raj Rai and Akorn, Inc
Akorn
Pharmaceuticals
2018
Executive Agreement between Akorn, Inc. and Douglas S. Boothe, its President and Chief Executive Officer, dated December 20, 2018
Akorn
Pharmaceuticals
IL
2018
Offer Letter dated December 20, 2018
Akorn
Pharmaceuticals
2018
[Signature page follows]
Akorn
Pharmaceuticals
DE
2017
[Signature page follows]
Akorn
Pharmaceuticals
DE
2017
[Signature page follows]
Akorn
Pharmaceuticals
DE
2017
[Signature page follows]
Akorn
Pharmaceuticals
DE
2017
1925 West Field Court, Suite 300 Lake Forest, Illinois 60045 PHONE ###-###-#### FAX ###-###-#### www.akorn.com
Akorn
Pharmaceuticals
2016
Sterile
Akorn
Pharmaceuticals
2016
CONSENT MEMORANDUM
Akorn
Pharmaceuticals
2015
CONSENT MEMORANDUM
Akorn
Pharmaceuticals
2015
CONSENT MEMORANDUM
Akorn
Pharmaceuticals
2015
CONSENT MEMORANDUM
Akorn
Pharmaceuticals
2015
Exhibit 2.1
Akorn
Pharmaceuticals
NY
2014
DATED 6 OCTOBER 2011
Akorn
Pharmaceuticals
LA
2011
FIRST AMENDMENT TO
Akorn
Pharmaceuticals
IL
2010
AMENDMENTTO EXECUTIVE CONSULTINGAGREEMENT
Akorn
Pharmaceuticals
2009
AMENDED AND RESTATED
Akorn
Pharmaceuticals
IL
2009
AKORN, INC.
Akorn
Pharmaceuticals
2009
AMENDED AND RESTATED
Akorn
Pharmaceuticals
2009
AKORN, INC.
Akorn
Pharmaceuticals
2009
AMENDED AND RESTATED
Akorn
Pharmaceuticals
NJ
2009
AKORN, INC.
Akorn
Pharmaceuticals
2009
AKORN, INC.
Akorn
Pharmaceuticals
2009
MEMORANDUM OF AGREEMENT
Akorn
Pharmaceuticals
2009
MassBiologics University of Massachusetts Medical School 460 Walk Hill Street, Boston, MA 02126 Telephone: 617 ###-###-#### Facsimile: 617 ###-###-####
Akorn
Pharmaceuticals
2009
This instrument was prepared by and after recording, return to: Susan E. Foxworth, Esq. King & Spalding LLP 1180 Peachtree Street Atlanta, Georgia 30309 This space reserved for...
Akorn
Pharmaceuticals
IL
2009
This instrument was prepared by and after recording, return to: Susan E. Foxworth, Esq. King & Spalding LLP 1180 Peachtree Street Atlanta, Georgia 30309 This space reserved for...
Akorn
Pharmaceuticals
IL
2009
By: /s/ Arthur S. Przybyl Arthur S. Przybyl Its: Pres & CEO Date: 11/3/08
Akorn
Pharmaceuticals
NY
2008
CURRENT ASSETS
Akorn
Pharmaceuticals
2008
CURRENT ASSETS
Akorn
Pharmaceuticals
2008
CONSENT
Akorn
Pharmaceuticals
IL
2008